References
1. Bassetti M, Garnacho-Montero J, Calandra T, et al. Intensive care
medicine research agenda on invasive fungal infection in critically ill
patients. Intensive care medicine. 2017;43(9):1225-1238.
2. Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the
Consensus Definitions of Invasive Fungal Disease From the European
Organization for Research and Treatment of Cancer and the Mycoses Study
Group Education and Research Consortium. Clinical infectious
diseases : an official publication of the Infectious Diseases Society of
America. 2020;71(6):1367-1376.
3. Chen K, Zhang X, Ke X, Du G, Yang K, Zhai S. Individualized
Medication of Voriconazole: A Practice Guideline of the Division of
Therapeutic Drug Monitoring, Chinese Pharmacological Society.Therapeutic drug monitoring. 2018;40(6):663-674.
4. Cadena J, Thompson GR, 3rd, Patterson TF. Aspergillosis:
Epidemiology, Diagnosis, and Treatment. Infectious disease clinics
of North America. 2021;35(2):415-434.
5. Veringa A, Ter Avest M, Span LF, et al. Voriconazole metabolism is
influenced by severe inflammation: a prospective study. The
Journal of antimicrobial chemotherapy. 2017;72(1):261-267.
6. Gautier-Veyret E, Bailly S, Fonrose X, et al. Pharmacogenetics may
influence the impact of inflammation on voriconazole trough
concentrations. 2017;18(12):1119-1123.
7. Ivanov M, Barragan I, Ingelman-Sundberg M. Epigenetic mechanisms of
importance for drug treatment. Trends in Pharmacological
Sciences. 2014;35(8):384-396.
8. Fisel P, Schaeffeler E, Schwab M. DNA Methylation of ADME Genes.Clinical pharmacology and therapeutics. 2016;99(5):512-527.
9. Hao X, Li Y, Bian J, et al. Impact of DNA methylation on ADME gene
expression, drug disposition, and efficacy. Drug metabolism
reviews. 2022;54(2):194-206.
10. Tang X, Ge L, Chen Z, et al. Methylation of the Constitutive
Androstane Receptor Is Involved in the Suppression of CYP2C19 in
Hepatitis B Virus-Associated Hepatocellular Carcinoma. Drug
metabolism and disposition: the biological fate of chemicals.2016;44(10):1643-1652.
11. Burns KE, Shepherd P, Finlay G, Tingle MD, Helsby NA. Indirect
regulation of CYP2C19 gene expression via DNA methylation.Xenobiotica; the fate of foreign compounds in biological systems.2018;48(8):781-792.
12. Bian J, Zhao J, Zhao Y, et al. Impact of individual factors on DNA
methylation of drug metabolism genes: A systematic review.Environmental and Molecular Mutagenesis. 2023;64(7):401-415.
13. Burns KE, Lo WY, Findlay MP, Sharples K, Laking G, Helsby NA. High
CYP2C19 phenotypic variability in gastrointestinal cancer patients.Cancer chemotherapy and pharmacology. 2015;77(1):195-204.
14. Helsby NA, Lo WY, Sharples K, et al. CYP2C19 pharmacogenetics in
advanced cancer: compromised function independent of genotype.British Journal of Cancer. 2008;99(8):1251-1255.
15. Burns KE, Goldthorpe MA, Porteus F, Browett P, Helsby NA. CYP2C19
genotype-phenotype discordance in patients with multiple myeloma leads
to an acquired loss of drug-metabolising activity. Cancer
chemotherapy and pharmacology. 2014;73(3):651-655.
16. Clermont V, Grangeon A, Barama A, et al. Activity and mRNA
expression levels of selected cytochromes P450 in various sections of
the human small intestine. British journal of clinical
pharmacology. 2019;85(6):1367-1377.
17. Sukmawan R, Hoetama E, Suridanda Danny S, et al. Increase in the
risk of clopidogrel resistance and consequent TIMI flow impairment by
DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary
percutaneous coronary intervention (PPCI). Pharmacology research
& perspectives. 2021;9(2):e00738.
18. van Wanrooy MJ, Span LF, Rodgers MG, et al. Inflammation is
associated with voriconazole trough concentrations. Antimicrobial
agents and chemotherapy. 2014;58(12):7098-7101.
19. Luo X, Li T, Hu L, et al. Differential effects of C-reactive protein
levels on voriconazole metabolism at three age groups in allogeneic
hematopoietic cell transplant recipients. Journal of chemotherapy
(Florence, Italy). 2021;33(2):95-105.
20. Netea MG, Balkwill F, Chonchol M, et al. A guiding map for
inflammation. Nat Immunol. 2017;18(8):826-831.
21. Renton KW. Regulation of drug metabolism and disposition during
inflammation and infection. Expert opinion on drug metabolism &
toxicology. 2005;1(4):629-640.
22. Deb S, Arrighi S. Potential Effects of COVID-19 on Cytochrome
P450-Mediated Drug Metabolism and Disposition in Infected Patients.European journal of drug metabolism and pharmacokinetics.2021;46(2):185-203.
23. Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing
enzymes and transporters in inflammation. Annual review of
pharmacology and toxicology. 2006;46:123-149.
24. Roffey SJ, Cole S, Comby P, et al. The disposition of voriconazole
in mouse, rat, rabbit, guinea pig, dog, and human. Drug metabolism
and disposition: the biological fate of chemicals. 2003;31(6):731-741.
25. Li J, Ma J, Wagar EA, Liang D, Meng QH. A rapid ultra-performance
LC-MS/MS assay for determination of serum unbound fraction of
voriconazole in cancer patients. Clinica chimica acta;
international journal of clinical chemistry. 2018;486:36-41.
26. Chantharit P, Tantasawat M, Kasai H, Tanigawara Y. Population
Pharmacokinetics of Voriconazole in Patients With Invasive
Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and
Dosage Optimization. Therapeutic drug monitoring.2020;42(6):872-879.
27. Zhong XB, Lai Y. Special Section On Drug Metabolism in Liver Injury
and Repair-Editorial. Drug metabolism and disposition: the
biological fate of chemicals. 2022;50(5):634-635.
28. Tang D, Yan M, Song BL, et al. Population pharmacokinetics, safety
and dosing optimization of voriconazole in patients with liver
dysfunction: A prospective observational study. British journal of
clinical pharmacology. 2021;87(4):1890-1902.
29. Liang Z, Yu M, Liu Z, et al. Inflammation Affects Liver Function and
the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and
Elderly Patients. Frontiers in pharmacology. 2022;13:835871.
30. Olsson Lindvall M, Angerfors A, Andersson B, et al. Comparison of
DNA Methylation Profiles of Hemostatic Genes between Liver Tissue and
Peripheral Blood within Individuals. Thrombosis and haemostasis.2021;121(5):573-583.
31. Xu L, Wang Y. Combined influence of ABCB1 genetic polymorphism and
DNA methylation on aspirin resistance in Chinese ischemic stroke
patients. Acta neurologica Belgica. 2021.
32. Li X, Zhao K, Ma N, Sun S, Miao Z, Zhao Z. Association of ABCB1
promoter methylation with aspirin exposure, platelet function, and
clinical outcomes in Chinese intracranial artery stenosis patients.European journal of clinical pharmacology. 2017;73(10):1261-1269.